RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
+6.12%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.82B
AUM Growth
+$1.82B
(-1.5%)
Cap. Flow
-$72.9M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
265
New
15
Increased
38
Reduced
176
Closed
16
Top Buys
| 1 |
Shift4
FOUR
|
$21.3M |
| 2 |
LKQ Corp
LKQ
|
$13.1M |
| 3 |
Protolabs
PRLB
|
$5.97M |
| 4 |
Gentex
GNTX
|
$4.87M |
| 5 |
PRMB
Primo Brands Corporation
PRMB
|
$4.39M |
Top Sells
| 1 |
Stride
LRN
|
$16.9M |
| 2 |
Clear Secure
YOU
|
$8.3M |
| 3 |
SiTime
SITM
|
$7.56M |
| 4 |
Doximity
DOCS
|
$7.11M |
| 5 |
MGP Ingredients
MGPI
|
$6.55M |
Sector Composition
| 1 | Healthcare | 30.8% |
| 2 | Technology | 27.79% |
| 3 | Industrials | 15.67% |
| 4 | Communication Services | 7.19% |
| 5 | Consumer Discretionary | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Radware
RDWR
$1.06B
| $19.9M | 1.09% |
882,134
-49,517
| -5% | -$1.12M |
|
27
WIX.com
WIX
$8.05B
| $19.3M | 1.06% |
89,778
-4,507
| -5% | -$967K |
|
28
Supernus Pharmaceuticals
SUPN
$2.52B
| $19.1M | 1.05% |
528,345
-12,443
| -2% | -$450K |
|
29
Shutterstock
SSTK
$746M
| $16.6M | 0.91% |
547,520
+18,133
| +3% | +$550K |
|
|
30
LKQ Corp
LKQ
$8.23B
| $16.3M | 0.89% |
443,030
+355,815
| +408% | +$13.1M |
|
31
CRA International
CRAI
$1.28B
| $15.8M | 0.87% |
84,647
-1,823
| -2% | -$341K |
|
32
Ituran Location and Control
ITRN
$653M
| $15.8M | 0.87% |
507,552
-9,147
| -2% | -$285K |
|
33
BioCryst Pharmaceuticals
BCRX
$1.74B
| $15.7M | 0.86% |
2,081,316
-82,427
| -4% | -$620K |
|
34
Neurocrine Biosciences
NBIX
$13.5B
| $15.1M | 0.83% |
110,632
-6,785
| -6% | -$926K |
|
35
RB Global
RBA
$21.3B
| $14.9M | 0.82% |
165,652
-8,392
| -5% | -$757K |
|
36
Ingevity
NGVT
$2.14B
| $14.5M | 0.8% |
356,269
-23,402
| -6% | -$954K |
|
37
CEVA Inc
CEVA
$520M
| $14.1M | 0.78% |
447,361
-5,180
| -1% | -$163K |
|
|
38
Gentex
GNTX
$6.07B
| $13.1M | 0.72% |
454,883
+169,586
| +59% | +$4.87M |
|
39
Amicus Therapeutics
FOLD
$2.42B
| $12.9M | 0.71% |
1,371,080
+398,942
| +41% | +$3.76M |
|
40
Amdocs
DOX
$9.31B
| $12.9M | 0.71% |
151,658
-15,365
| -9% | -$1.31M |
|
41
Maximus
MMS
$4.99B
| $12.9M | 0.71% |
172,546
-1,233
| -0.7% | -$92K |
|
42
Bank OZK
OZK
$5.93B
| $12.8M | 0.7% |
287,016
-22,335
| -7% | -$995K |
|
43
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $12.7M | 0.7% |
642,752
-6,878
| -1% | -$136K |
|
44
Acadia Pharmaceuticals
ACAD
$4.34B
| $12.5M | 0.69% |
681,537
-35,609
| -5% | -$653K |
|
45
Alkermes
ALKS
$4.95B
| $12.4M | 0.68% |
429,927
-21,730
| -5% | -$625K |
|
46
Iovance Biotherapeutics
IOVA
$800M
| $11.8M | 0.65% |
1,594,532
-84,625
| -5% | -$626K |
|
47
Pool Corp
POOL
$11.4B
| $11.6M | 0.64% |
33,967
-2,930
| -8% | -$999K |
|
48
Vail Resorts
MTN
$5.91B
| $11.1M | 0.61% |
59,215
-3,096
| -5% | -$580K |
|
49
Liquidity Services
LQDT
$824M
| $10.8M | 0.59% |
334,255
-33,047
| -9% | -$1.07M |
|
50
Aehr Test Systems
AEHR
$734M
| $10.5M | 0.58% |
634,391
+235,625
| +59% | +$3.92M |
|